Open Access
Table 2
Baseline characteristics and reported comorbidities for renal replacement therapy in patients requiring mechanical circulatory support.
| Terms | Estimates | Std Error | χ2 | P values |
|---|---|---|---|---|
| Intercept | 3.7 | 1.6 | 5.7 | 0.0171 |
| Age | −0.07 | 0.02 | 12.5 | 0.0004* |
| Sex, female | −0.04 | 0.26 | 2.5 | 0.1159 |
| BMI | −0.01 | 0.04 | 0.2 | 0.6909 |
| Insulin-dependent diabetes | 1.4 | 1.4 | 1.0 | 0.3194 |
| Chronic renal failure | 0.3 | 0.3 | 0.5 | 0.4608 |
| Chronic cardiovascular disease | 0.4 | 0.3 | 1.5 | 0.2261 |
| Immunomodulation | 0.8 | 0.3 | 7.3 | 0.0067* |
| Structural lung disease | −0.3 | 0.3 | 0.9 | 0.3343 |
| Pacemaker/Internal cardiac defibrillator | 0.6 | 0.3 | 4.2 | 0.0411* |
| Atrial fibrillation | 0.3 | 0.3 | 1.4 | 0.2430 |
| Endocarditis | 0.4 | 0.7 | 0.3 | 0.5936 |
| Previous cardiac surgery | 0.3 | 0.2 | 0.9 | 0.3357 |
| Congestive heart failure | −0.6 | 0.3 | 3.0 | 0.0845 |
| Peripheral vascular disease | −0.02 | 0.5 | 0 | 0.9611 |
(*) Denotes the baseline characteristics and comorbidities associated with the outcome of interest, the need for renal replacement therapy, are statistically significant.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.